Discover 1,876 paid clinical trials in Minnesota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
Hennepin Healthcare Research Institute
Location:
Code:
NCT06147076
Conditions
Kidney Transplant
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Social Support Network Counseling Intervention
Sponsor:
University Medical Center Nijmegen
Location:
Code:
NCT04294927
Conditions
BRCA1 Gene Mutation
BRCA2 Gene Mutation
RAD51C Gene Mutation
RAD51D Gene Mutation
BRIP1 Gene Mutation
Eligibility Criteria
Sex: Female
Age: 25 - 50
Healthy Volunteers: Not accepted
Interventions
Risk-reducing salpingectomy with delayed oophorectomy
Risk-reducing salpingo-oophorectomy
Sponsor:
AbbVie
Location:
Code:
NCT05814627
Conditions
Rheumatoid Arthritis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Upadacitinib
Adalimumab
Upadacitinib Matching Placebo
Adalimumab Matching Placebo
Sponsor:
Regeneron Pharmaceuticals
Location:
Code:
NCT05831176
Conditions
Eosinophilic Gastritis
Eosinophilic Duodenitis
Eosinophilic Gastrointestinal Disease
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Dupilumab Dose 1
Dupilumab Dose 2
Matching Placebo
Sponsor:
University of Minnesota
Location:
Code:
NCT06735027
Conditions
Glenohumeral Arthritis
Rotator Cuff Arthropathy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
intraarticular corticosteroid injection (IACI)
suprascapular nerve block (SSNB)
Sponsor:
Keryx Biopharmaceuticals
Location:
Code:
NCT04523727
Conditions
Hyperphosphatemia Related to Chronic Kidney Disease
Eligibility Criteria
Sex: All
Age: 6 - 16
Healthy Volunteers: Not accepted
Interventions
ferric citrate
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04181060
Conditions
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
Stage IIIB Lung Cancer AJCC v8
Stage IV Lung Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bevacizumab
Biospecimen Collection
Computed Tomography
Echocardiography
Magnetic Resonance Imaging
Sponsor:
International Consortium of Circulatory Assist Clinicians
Location:
Code:
NCT06039176
Conditions
LVAD
Frailty
GI Bleed
Right Heart Failure
Infections
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
HeartMate 3 (R) left ventricular assist device
Sponsor:
Edwards Lifesciences
Location:
Code:
NCT05526560
Conditions
Mitral Stenosis
Mitral Valve Insufficiency
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MITRIS RESILIA Mitral Valve, Model 11400M
Minnesota offers a strong healthcare network and renowned medical research institutions, making it a prominent hub for a wide range of clinical trials. Leading organizations such as the Mayo Clinic, University of Minnesota Medical School, and Hennepin Healthcare are at the forefront of cutting-edge research.
These institutions are recognized globally for their contributions to medical advancements, placing Minnesota as a key player in clinical trials across various medical fields, from cancer and cardiovascular research to neurological and rare diseases.
For people considering participation in a clinical trial, Minnesota provides distinct advantages. The state is home to a diverse and engaged population, which enriches the pool of participants and enhances the relevance of research findings. Minnesota is also renowned for its innovative healthcare landscape, highlighted by institutions that are at the forefront of medical research and technological advancements.
By choosing to participate in a clinical trial in Minnesota, participants can contribute to significant medical research while benefiting from a well-established and collaborative clinical research environment that prioritizes patient safety and care.
Minnesota is a prominent center for clinical research, particularly known for its focus on several key medical conditions.
Minnesota has made significant contributions to diabetes research, especially regarding Type 1 diabetes. The University of Minnesota’s Diabetes Institute conducts clinical trials focused on prevention strategies, management techniques, and innovative therapies, including potential immunotherapies and artificial pancreas systems.
Given the rising prevalence of diabetes in the region, these studies aim to address both immediate patient needs and long-term public health challenges associated with metabolic disorders.
The Mayo Clinic is a global leader in oncology research, conducting extensive clinical trials on a wide range of cancers, including breast, prostate, lung, and pancreatic cancer. Its comprehensive cancer center in Minnesota is distinguished for its pioneering work in personalized medicine and immunotherapy, utilizing advanced genomic techniques to tailor treatments to individual patients.
Oncology research carried out in Minnesota aims to enhance therapeutic efficacy and minimize side effects, contributing significantly to improved survival rates and quality of life for cancer patients.
The state of Minnesota is particularly renowned for its research on neurological conditions, including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis (MS). The Mayo Clinic and the University of Minnesota lead extensive studies exploring new diagnostic tools and treatment modalities. These trials investigate everything from pharmacological therapies to lifestyle interventions that can help slow disease progression or improve symptoms.
Minnesota has a robust focus on cardiovascular health, with leading institutions like the University of Minnesota actively conducting trials on heart disease, heart failure, and stroke prevention. Research efforts in Minnesota often explore innovative interventions, such as new surgical techniques, minimally invasive procedures, and advanced medical devices, including stents and pacemakers.
The state’s commitment to cardiovascular research not only aims to improve patient outcomes but also seeks to develop effective strategies for managing risk factors like hypertension and diabetes.
Minnesota prioritizes mental health research, studying various conditions such as depression, anxiety, and schizophrenia. Clinical trials in this area focus on new pharmacological treatments, psychotherapeutic interventions, and alternative therapies, including mindfulness and behavioral approaches.
Minnesota research institutions are dedicated to developing effective treatment modalities that can help improve mental health outcomes and reduce the stigma associated with mental illness.
Institutions like the Mayo Clinic in Minnesota are at the forefront of research on rare genetic and metabolic disorders, conducting clinical trials aimed at developing targeted therapies and enhancing the understanding of these conditions. These trials are vital for patients who often face limited treatment options.
Rare diseases being studied include cystic fibrosis, muscular dystrophy, hemophilia, and amyotrophic lateral sclerosis (ALS), among others. By exploring genetic therapies and novel drug candidates, researchers aim to provide new hope for individuals affected by these challenging conditions.
In Minnesota, clinical trials are governed by both federal and state regulations to ensure the safety and rights of participants. Key federal guidelines include the requirements set by the Food and Drug Administration (FDA) and the Office for Human Research Protections (OHRP), which mandate Institutional Review Board (IRB) approval, informed consent, and adherence to Good Clinical Practice (GCP) standards.
At state level, Minnesota has specific laws that align with federal protections for human subjects, emphasizing the importance of ethical oversight in medical research. The Minnesota Department of Health plays a role in overseeing health research initiatives, and ensuring compliance with public health regulations. Additionally, local institutions have established rigorous internal policies and IRBs to safeguard participant rights and maintain high research standards. This collaborative framework fosters a supportive environment for conducting clinical trials while prioritizing participant welfare.
Clinical trial participation provides individuals with a unique opportunity to access groundbreaking treatments and therapies that are not yet widely available. This is especially advantageous for those whose conditions have not improved with standard treatments. Participants also benefit from access to dedicated medical professionals who closely monitor their health throughout the trial, ensuring safety while evaluating the effectiveness of new interventions.
Moreover, engaging in clinical trials is vital for the progress of medical research. By becoming participants, individuals not only gain access to potentially life-changing therapies but also contribute to the advancement of healthcare practices on a global scale. Involvement in clinical research can lead to significant discoveries that enhance our understanding of diseases and improve treatment options, ultimately offering new hope to many patients facing challenging health issues.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: